Cyclofenil is a modulator of estrogen receptor and is used clinically as an ovulation-inducing drug with antiviral activity. However, the mechanism by which cyclofenil works without estrogen receptor ...

Osteoarthritis (OA) is a common degenerative disease characterized by chondrocyte death and extracellular matrix (ECM) degradation, but the present OA treatments are only symptomatic and not ...

Deep cuts from accidents or surgeries require stitches, typically followed by oral anti-inflammatory medications like ibuprofen. While these medications help with pain, they don't act specifically on ...

Patients with type 2 diabetes taking cetirizine, ibuprofen, or prednisone have a lower risk of developing diabetic retinopathy than matched nonusers, a retrospective study shows.

The oral corticosteroid can bring swift relief from pain and swelling — but its many possible side effects and longer-term ...

A new study published this week in Molecular Psychiatry by Emory University researchers has revealed a promising new avenue for treating motivational deficits in patients suffering from depression.

NSAIDs block an enzyme called COX to reduce pain and inflammation. NSAIDs should be used at the lowest dose and for the shortest time possible. Celebrex is the only COX-2 inhibitor available in the ...

Antibiotics, antivirals, vaccinations and anti-inflammatory medication are associated with reduced risk of dementia, according to new research that looked at health data from over 130 million ...

A preclinical study finds that a drug already FDA-approved for treating inflammatory conditions may help reduce both alcohol intake and pain sensitivity -- two issues that commonly co-occur with ...

A man with pneumonia coughed for a week until bleeding in his abdominal wall made him unstable. He took no blood thinners, making the case rare. Shreveport Precautionary Boil Advisory Covers 19 ...

Alzheimer's disease, the most common cause of dementia, is currently incurable. The current drugs available have very limited efficacy and only in mild stages of the disease. A team from the ...

A new study published this week in Molecular Psychiatry by Emory University researchers has revealed a promising new avenue for treating motivational deficits in patients suffering from depression.